论文部分内容阅读
目的比较雷贝拉唑(波利特)、阿莫西林、呋喃唑酮片、左氧氟沙星片组成的10d序贯疗法与标准三联疗法根除幽门螺杆菌的疗效。方法将我院经胃镜检查确诊为慢性胃炎和消化性溃疡且Hp阳性的93例患者随机分为二组,治疗组(47例)方案:前5d雷贝拉唑10mg+阿莫西林1 000mg,2次/d,后5d雷贝拉唑10mg+呋喃唑酮片0.2g+左氧氟沙星片0.2g,2次/d。对照组(46例)标准三联疗法:雷贝拉唑10mg+克拉霉素500mg+阿莫西林1 000mg,2次/d,疗程10d。结果治疗组Hp根除率为93.61%,对照组78.26%,二组比较差异具有统计学意义(P<0.05),且序贯疗法并未增加患者的经济负担,二种方案不良反应的发生率差异无统计学意义(P>0.05)。结论以雷贝拉唑(波利特)、阿莫西林、呋喃唑酮片、左氧氟沙星片组成的10d序贯疗法治疗Hp感染明显优于10d标准三联疗法,是一种安全、有效、经济的方案选择。
Objective To compare the efficacy of rabeprazole (pollitre), amoxicillin, furazolidone tablets and levofloxacin tablets in 10 days sequential therapy and standard triple therapy in the eradication of Helicobacter pylori. Methods Ninety-three patients diagnosed as chronic gastritis and peptic ulcer with Hp positive by gastroscopy in our hospital were randomly divided into two groups. The treatment group (n = 47) consisted of 10 mg of rabeprazole for the first 5 days and 1 000 mg for amoxicillin Times / d, after 5d rabeprazole 10mg + furazolidone tablets 0.2g + levofloxacin tablets 0.2g, 2 times / d. Control group (46 cases) standard triple therapy: rabeprazole 10mg + clarithromycin 500mg + amoxicillin 1000mg, 2 times / d, treatment 10d. Results The Hp eradication rate was 93.61% in the treatment group and 78.26% in the control group. The difference between the two groups was statistically significant (P <0.05), and the sequential therapy did not increase the economic burden of the patients. The incidence of adverse reactions in the two regimens No statistical significance (P> 0.05). Conclusions The 10d sequential therapy with rabeprazole, amoxicillin, furazolidone and levofloxacin is a safe, effective and economical alternative to Hp infection.